Sangamo Therapeutics (SGMOQ) EBT Margin (2010 - 2025)
Sangamo Therapeutics' EBT Margin came in at -266.88% for Q4 2025, up 48.61 percentage points from -315.49% a year earlier and up 5772.88 percentage points from the prior quarter.
Sangamo Therapeutics (SGMOQ) EBT Margin (2010 - 2025) Analysis & Trends
For FY2025, Sangamo Therapeutics' EBT Margin was -312.25%, down 142.51 percentage points from FY2024.
- EBT Margin carries a five-year change of -210.06 percentage points (FY2020 to FY2025).
- Going back by year, EBT Margin was -169.74% in FY2024 (-20.56 pp), -149.18% in FY2023 (+23.19 pp), -172.37% in FY2022 (-11.59 pp) and -160.79% in FY2021 (-58.60 pp).
- The five-year range for quarterly EBT Margin is -10185.24% (Q1 2024) to 21.78% (Q3 2024).
- Year-over-year, EBT Margin increased in five of the last eight quarters, with an average year-over-year change of -134.35 percentage points.
- The fastest year-over-year change in EBT Margin over five years came in Q2 2025 (a gain of 10018.50 percentage points), and the weakest in Q1 2024 (a drop of 10198.74 percentage points).
- Business Quant data shows SGMOQ's EBT Margin at -6039.76% (Q3 2025), -109.03% (Q2 2025) and -473.48% (Q1 2025) in the three quarters before Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 41.75% |
| 10 | Sangamo Therapeutics | 42.03 Mn | -72.08 Mn | - | -266.88% |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -266.88% |
| Sep 30, 2025 | -6,039.76% |
| Jun 30, 2025 | -109.03% |
| Mar 31, 2025 | -473.48% |
| Dec 31, 2024 | -315.49% |
| Sep 30, 2024 | 21.78% |
| Jun 30, 2024 | -10,127.53% |
| Mar 31, 2024 | -10,185.24% |
| Dec 31, 2023 | -2,966.06% |
| Sep 30, 2023 | -1,094.84% |
| Jun 30, 2023 | -1,766.93% |
| Mar 31, 2023 | 13.50% |
| Dec 31, 2022 | -189.92% |
| Sep 30, 2022 | -200.77% |
| Jun 30, 2022 | -146.68% |
| Mar 31, 2022 | -155.57% |
| Dec 31, 2021 | -134.22% |
| Sep 30, 2021 | -166.66% |
| Jun 30, 2021 | -169.17% |
| Mar 31, 2021 | -173.81% |
Sangamo Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();